2019
DOI: 10.1096/fj.201902040r
|View full text |Cite|
|
Sign up to set email alerts
|

Plumericin prevents intestinal inflammation and oxidative stress in vitro and in vivo

Abstract: Inflammatory bowel diseases (IBDs) are characterized by an inflammatory and oxidative stress condition in the intestinal tissue. In this study, we evaluated the effect of plumericin, one of the main bioactive components of Himatanthus sucuuba (Woodson) bark, on intestinal inflammation and oxidative stress, both in vitro and in vivo. The effect of plumericin (0.5‐2 µM) in vitro was evaluated in rat intestinal epithelial cells (IEC‐6) treated with lipopolysaccharides from E. coli (10 μg/mL) plus interferon‐γ (10… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
23
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
10

Relationship

5
5

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 52 publications
1
23
0
Order By: Relevance
“…27 Thus, the compounds were investigated for their effect on nitrotyrosine formation, as triggered by LPS in the HaCaT cells. 39 The results exhibited a notable inhibition of the nitrotyrosine formation by all compounds investigated in a concentration-dependent manner ( p < 0.001 vs LPS alone). Other important regulators in wound-healing processes are tight-junction proteins.…”
Section: Results and Discussionmentioning
confidence: 84%
“…27 Thus, the compounds were investigated for their effect on nitrotyrosine formation, as triggered by LPS in the HaCaT cells. 39 The results exhibited a notable inhibition of the nitrotyrosine formation by all compounds investigated in a concentration-dependent manner ( p < 0.001 vs LPS alone). Other important regulators in wound-healing processes are tight-junction proteins.…”
Section: Results and Discussionmentioning
confidence: 84%
“…IEC-6 cells were plated and allowed to adhere for 24 h at 37 °C in a 5% CO 2 atmosphere. ASE and formulation (CD-ASE; 50–5 μg/mL) were then added for 1 h and then co-exposed to lipopolysaccharides from E. coli (LPS; 10 μg/mL) plus interferon-γ (IFN; 10 U/mL) for different experimental times, as indicated below [ 20 ]. In order to further evaluate the antioxidant potential of almond ASE, and CD-ASE, in another set of experiments, the IEC-6 cells were incubated with the tested products (50–5 μg/mL) for 1 h alone, and then simultaneously to hydrogen peroxide (H 2 O 2 ; 1 mM) [ 21 ].…”
Section: Methodsmentioning
confidence: 99%
“…First, a fixing solution was added to the IEC-6 cells for 20 min and after the cells were incubated in fix perm solution for a further 30 min. Anti-cyclooxygenase-2 (COX-2; BD Transduction Laboratories, Milan, Italy), anti-inducible nitric oxide synthase (iNOS; BD Transduction Laboratories, Milan, Italy), anti-heme oxygenase-1 (HO-1; Santa Cruz Biotechnologies, Dallas, TX, USA), anti-NAD(P)H dehydrogenase (quinone) 1 (NQO1; Santa Cruz Biotechnologies, Dallas, TX, USA), anti-Bax (Santa Cruz Biotechnologies, Dallas, TX, USA), anti-Bcl-2 (Santa Cruz Biotechnologies, Dallas, TX, USA), anti-Bcl-xL (Thermofisher Scientific, Waltham, MA, USA), anti-caspase 3 (Thermofisher Scientific, Waltham, MA, USA), anti-claudin 1 (Thermofisher Scientific, Waltham, MA, USA), anti-Occludin (Thermofisher Scientific, Waltham, MA, USA), anti-Z-Occludin 1 (ZO-1; Thermofisher Scientific, Waltham, MA, USA), anti-E-cadherin (Cell Signaling Technology, Dellaertweg 9b, The Netherlands) or anti-nitrotyrosine (Merck Millipore, Milan, Italy) antibodies were then added for 1 h. The secondary antibody was added to IEC-6 cells in fixing solution and cell fluorescence was then evaluated by a fluorescence-activated cell sorter (FACSscan; Becton Dickinson, Milan, Italy) and then elaborated by Cell Quest software (version 4; Becton Dickinson, Milan, Italy) [27].…”
Section: Tnf-α Il-6 and Il-1β Determinationmentioning
confidence: 99%